S&P 500   4,967.23 (-0.88%)
DOW   37,986.40 (+0.56%)
QQQ   414.65 (-2.07%)
AAPL   165.00 (-1.22%)
MSFT   399.12 (-1.27%)
META   481.07 (-4.13%)
GOOGL   154.09 (-1.23%)
AMZN   174.63 (-2.56%)
TSLA   147.05 (-1.92%)
NVDA   762.00 (-10.00%)
AMD   146.64 (-5.44%)
NIO   3.80 (-5.00%)
BABA   69.07 (+0.28%)
T   16.51 (+1.10%)
F   12.14 (+0.66%)
MU   106.77 (-4.61%)
GE   148.06 (-3.19%)
CGC   7.93 (+1.28%)
DIS   112.61 (+0.16%)
AMC   3.16 (+8.22%)
PFE   26.00 (+2.40%)
PYPL   62.31 (+0.34%)
XOM   119.88 (+1.15%)
S&P 500   4,967.23 (-0.88%)
DOW   37,986.40 (+0.56%)
QQQ   414.65 (-2.07%)
AAPL   165.00 (-1.22%)
MSFT   399.12 (-1.27%)
META   481.07 (-4.13%)
GOOGL   154.09 (-1.23%)
AMZN   174.63 (-2.56%)
TSLA   147.05 (-1.92%)
NVDA   762.00 (-10.00%)
AMD   146.64 (-5.44%)
NIO   3.80 (-5.00%)
BABA   69.07 (+0.28%)
T   16.51 (+1.10%)
F   12.14 (+0.66%)
MU   106.77 (-4.61%)
GE   148.06 (-3.19%)
CGC   7.93 (+1.28%)
DIS   112.61 (+0.16%)
AMC   3.16 (+8.22%)
PFE   26.00 (+2.40%)
PYPL   62.31 (+0.34%)
XOM   119.88 (+1.15%)
S&P 500   4,967.23 (-0.88%)
DOW   37,986.40 (+0.56%)
QQQ   414.65 (-2.07%)
AAPL   165.00 (-1.22%)
MSFT   399.12 (-1.27%)
META   481.07 (-4.13%)
GOOGL   154.09 (-1.23%)
AMZN   174.63 (-2.56%)
TSLA   147.05 (-1.92%)
NVDA   762.00 (-10.00%)
AMD   146.64 (-5.44%)
NIO   3.80 (-5.00%)
BABA   69.07 (+0.28%)
T   16.51 (+1.10%)
F   12.14 (+0.66%)
MU   106.77 (-4.61%)
GE   148.06 (-3.19%)
CGC   7.93 (+1.28%)
DIS   112.61 (+0.16%)
AMC   3.16 (+8.22%)
PFE   26.00 (+2.40%)
PYPL   62.31 (+0.34%)
XOM   119.88 (+1.15%)
S&P 500   4,967.23 (-0.88%)
DOW   37,986.40 (+0.56%)
QQQ   414.65 (-2.07%)
AAPL   165.00 (-1.22%)
MSFT   399.12 (-1.27%)
META   481.07 (-4.13%)
GOOGL   154.09 (-1.23%)
AMZN   174.63 (-2.56%)
TSLA   147.05 (-1.92%)
NVDA   762.00 (-10.00%)
AMD   146.64 (-5.44%)
NIO   3.80 (-5.00%)
BABA   69.07 (+0.28%)
T   16.51 (+1.10%)
F   12.14 (+0.66%)
MU   106.77 (-4.61%)
GE   148.06 (-3.19%)
CGC   7.93 (+1.28%)
DIS   112.61 (+0.16%)
AMC   3.16 (+8.22%)
PFE   26.00 (+2.40%)
PYPL   62.31 (+0.34%)
XOM   119.88 (+1.15%)
NASDAQ:IPWR

Ideal Power (IPWR) Stock Price, News & Analysis

$6.95
-0.27 (-3.74%)
(As of 05:37 PM ET)
Today's Range
$6.92
$7.47
50-Day Range
$6.80
$13.27
52-Week Range
$6.61
$13.98
Volume
41,481 shs
Average Volume
36,579 shs
Market Capitalization
$51.22 million
P/E Ratio
N/A
Dividend Yield
N/A
Price Target
$14.00

Ideal Power MarketRank™ Stock Analysis

Analyst Rating
Buy
3.00 Rating Score
Upside/​Downside
101.4% Upside
$14.00 Price Target
Short Interest
Healthy
1.07% of Float Sold Short
Dividend Strength
N/A
Sustainability
N/A
News Sentiment
1.02mentions of Ideal Power in the last 14 days
Based on 4 Articles This Week
Insider Trading
N/A
Proj. Earnings Growth
N/A

Overall MarketRank

New Rank-Based ScoringMarketRank is calculated by averaging available category scores (with extra weight given to analysis and valuation), then ranking the company's weighted average against that of other companies.

2.27 out of 5 stars

Industrial Products Sector

125th out of 167 stocks

Semiconductors & Related Devices Industry

59th out of 87 stocks

IPWR stock logo

About Ideal Power Stock (NASDAQ:IPWR)

Ideal Power Inc. focuses on the development and commercialization of its bidirectional bipolar junction TRANsistor solid-state switch technology. The company offers SymCool Power Module designed to meet low conduction loss needs of the solid-state circuit breaker market. It serves electric and hybrid electric vehicles, electric vehicle charging, renewable energy and energy storage system power converters, uninterruptible power supplies for data centers, industrial motor drives, solid-state circuit breakers, distribution and transmission switches and controls, and other industrial and military markets. The company was formerly known as Ideal Power Converters Inc. and changed its name to Ideal Power Inc. in July 2013. Ideal Power Inc. was incorporated in 2007 and is headquartered in Austin, Texas.

IPWR Stock Price History

IPWR Stock News Headlines

Ideal Power Inc. (IPWR)
Tiny Biotech Stock Wins $75 Billion Patent
A little-known biotech has been quietly working on revolutionary treatments for neurodegenerative diseases. Most people have never heard of them... but those in the know have been taking notice. Jeff Bezos cut them a check for $130 million. Fidelity Biosciences for a further $217 million. They've even had several collaborative partnerships with much larger companies like Biogen, Sanofi, and Takeda.
Tiny Biotech Stock Wins $75 Billion Patent
A little-known biotech has been quietly working on revolutionary treatments for neurodegenerative diseases. Most people have never heard of them... but those in the know have been taking notice. Jeff Bezos cut them a check for $130 million. Fidelity Biosciences for a further $217 million. They've even had several collaborative partnerships with much larger companies like Biogen, Sanofi, and Takeda.
Benchmark Co. Keeps Their Buy Rating on Ideal Power (IPWR)
Q4 2023 Ideal Power Inc Earnings Call
Ideal Power: Q4 Earnings Insights
Ideal Power Up 17% on Progress in Stellantis Program
Compare with Ideal Power Inc (IPWR)
See More Headlines
Receive IPWR Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for Ideal Power and its competitors with MarketBeat's FREE daily newsletter.

Company Calendar

Last Earnings
2/29/2024
Today
4/19/2024
Next Earnings (Estimated)
5/02/2024
Fiscal Year End
12/31/2024

Industry, Sector and Symbol

Industry
Semiconductors & related devices
Sub-Industry
N/A
Current Symbol
NASDAQ:IPWR
Employees
8
Year Founded
2007

Price Target and Rating

Average Stock Price Target
$14.00
High Stock Price Target
$14.00
Low Stock Price Target
$14.00
Potential Upside/Downside
+101.4%
Consensus Rating
Buy
Rating Score (0-4)
3.00
Research Coverage
1 Analysts

Profitability

Net Income
$-9,950,000.00
Net Margins
-4,977.50%
Pretax Margin
-5,005.25%

Debt

Sales & Book Value

Annual Sales
$200,000.00
Book Value
$1.69 per share

Miscellaneous

Free Float
6,999,000
Market Cap
$51.22 million
Optionable
Not Optionable
Beta
1.01

Social Links

Ten Starter Stocks For Beginners to Buy Now Cover

Just getting into the stock market? These 10 simple stocks can help beginning investors build long-term wealth without knowing options, technicals, or other advanced strategies.

Get This Free Report

IPWR Stock Analysis - Frequently Asked Questions

Should I buy or sell Ideal Power stock right now?

1 Wall Street equities research analysts have issued "buy," "hold," and "sell" ratings for Ideal Power in the last twelve months. There are currently 1 buy rating for the stock. The consensus among Wall Street equities research analysts is that investors should "buy" IPWR shares.
View IPWR analyst ratings
or view top-rated stocks.

What is Ideal Power's stock price target for 2024?

1 Wall Street analysts have issued 1 year target prices for Ideal Power's stock. Their IPWR share price targets range from $14.00 to $14.00. On average, they anticipate the company's stock price to reach $14.00 in the next year. This suggests a possible upside of 101.4% from the stock's current price.
View analysts price targets for IPWR
or view top-rated stocks among Wall Street analysts.

How have IPWR shares performed in 2024?

Ideal Power's stock was trading at $7.77 on January 1st, 2024. Since then, IPWR shares have decreased by 10.6% and is now trading at $6.95.
View the best growth stocks for 2024 here
.

Are investors shorting Ideal Power?

Ideal Power saw a decline in short interest in March. As of March 31st, there was short interest totaling 75,500 shares, a decline of 6.3% from the March 15th total of 80,600 shares. Based on an average daily volume of 37,500 shares, the short-interest ratio is currently 2.0 days. Approximately 1.1% of the company's stock are sold short.
View Ideal Power's Short Interest
.

When is Ideal Power's next earnings date?

The company is scheduled to release its next quarterly earnings announcement on Thursday, May 2nd 2024.
View our IPWR earnings forecast
.

How were Ideal Power's earnings last quarter?

Ideal Power Inc. (NASDAQ:IPWR) announced its earnings results on Thursday, February, 29th. The industrial products company reported ($0.39) earnings per share (EPS) for the quarter. The industrial products company earned $0.06 million during the quarter. Ideal Power had a negative trailing twelve-month return on equity of 75.69% and a negative net margin of 4,977.50%.

What other stocks do shareholders of Ideal Power own?

Based on aggregate information from My MarketBeat watchlists, some companies that other Ideal Power investors own include XOMA (XOMA), Plug Power (PLUG), Biocept (BIOC), Maxar Technologies (MAXR), Rite Aid (RAD), Energous (WATT), Ardelyx (ARDX), Novavax (NVAX).

How do I buy shares of Ideal Power?

Shares of IPWR stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Charles Schwab, E*TRADE, Fidelity, and Vanguard Brokerage Services.
Compare Top Brokerages Here.

This page (NASDAQ:IPWR) was last updated on 4/19/2024 by MarketBeat.com Staff

From Our Partners